US STOCK
RPRX Stock Analysis
US stocks · market data · technical indicators
Royalty Pharma plc Class A Ordinary Shares
RPRXUS stocksQuote delayed 15 min
10/26 上午10:34 updated
$63.86
+0.11+0.17%
Open
$63.50
High
$63.97
Low
$63.01
Volume
401.57萬
RPRX price history
+9.41%Open
58.37
Latest
63.86
High
63.86
Low
56.21
Average
58.95
Advertisement
Financial snapshot
RPRX - Royalty Pharma plc
EPS
1.88USD
Forward EPS
5.81USD
P/E
33.97x
Forward P/E
10.99x
P/B
4.17x
ROE
13.97%
ROA
5.09%
Operating margin
19.75%
Profit margin
32.02%
Revenue growth
16.50%
Earnings growth
-46.30%
Dividend yield
1.47%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $674.14M | $630.58M | $621.99M | $609.29M | $578.66M |
| Operating income | $133.12M | $632.48M | $388.38M | $427.16M | $209.80M |
| Net income | $17.88M | $294.69M | $214.21M | $288.22M | $32.18M |
| Basic EPS | 0.04 | 0.66 | 0.50 | 0.67 | 0.07 |
| Diluted EPS | 0.03 | 0.53 | 0.38 | 0.51 | 0.05 |
Estimates vs actuals
Next earnings
2026-11-04
EPS estimate
1.18
Revenue estimate
$884.84M
Last surprise
+3.85%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-04 | 1.18 | Not reported | — |
| 2026-08-05 | 1.27 | 1.32 | +3.85% |
| 2026-05-06 | 1.18 | 1.30 | +9.39% |
| 2026-02-11 | 1.33 | 1.47 | +9.95% |
| 2025-11-05 | 1.04 | 1.17 | +12.53% |
| 2025-08-06 | 1.03 | 1.14 | +10.48% |
| 2025-05-08 | 0.95 | 1.06 | +10.77% |
| 2025-02-11 | 1.05 | 1.15 | +9.21% |
| 2024-11-06 | 0.93 | 1.04 | +12.07% |
| 2024-08-08 | 0.97 | 0.96 | -0.38% |
| 2024-05-09 | 0.98 | 0.98 | -0.35% |
| 2024-02-15 | 1.00 | 1.52 | +51.70% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| STATE STREET CORP | 2026-06-30 | $691.8M | 0.02% |
| BlackRock Inc. | 2024-06-30 | $607M | 0.01% |
| VANGUARD GROUP INC | 2025-12-31 | $383.9M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $163.7M | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $108.5M | 0.15% |
| CITADEL ADVISORS LLC | 2026-06-30 | $76M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $12.3M | 0.05% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$65.38
Target range
$61.00 – $70.00
Implied upside
2.37%
Strong buy
2
Buy
5
Hold
1
Sell
0
Strong sell
0
Dividends
Annual yield
1.45%
Frequency
Quarterly
Recent payouts
- 2026-08-14$0.2350
- 2026-05-15$0.2350
- 2026-02-20$0.2350
- 2025-11-14$0.2200
Advertisement